Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab

Saskia Räuber, David Kremer, Philipp Albrecht et al.|Frontiers in Immunology|2022

Cited by 9